Lenacapavir is a new HIV drug with remarkable potential. Acting as prevention and treatment, it is 99.9% effective and longlasting–one course covers you for 6 months.
People at risk of HIV face considerable economic disadvantages, which has been addressed in recent philanthropy efforts to support the rollout of Lenacapavir. Read this infographic to learn more about the mechanism of this intriguing new treatment.
Audience
Science magazine readers
Tools
Molecular modelling: ChimeraX, VMD, Maya
Editing & layout: Photoshop, Illustrator, Procreate
Client
Dr. Derek Ng (University of Toronto)
Process work coming soon!